News

The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement ...
Amid a multi-year surge in vaccine misinformation sparked by the Covid-19 pandemic, social media posts claimed that the ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
The survey found that one-third of people globally either reject or are unsure about traditional vaccines despite decades of ...
Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday. The news sent company shares ...
Peter Kotlár has long promoted fringe theories about mRNA vaccines, claiming they "cause the human body to produce toxins." ...
The first patients have been dosed in a phase 3 trial of an mRNA ... vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than shots made using ...